The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMutlu, Hasan
dc.contributor.authorGunduz, Seyda
dc.contributor.authorBuyukcelik, Abdullah
dc.contributor.authorYildiz, Ozcan
dc.contributor.authorUysal, Mukremin
dc.contributor.authorTural, Deniz
dc.contributor.authorBozcuk, Hakan
dc.contributor.authorCoskun, Hasan Senol
dc.date.accessioned2025-10-16T15:32:09Z
dc.date.issued2014
dc.identifier.doi10.1016/j.clgc.2014.06.006
dc.identifier.otherWOS:000345547700009
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9105
dc.publisherCIG MEDIA GROUP, LP
dc.sourceCLINICAL GENITOURINARY CANCER
dc.subjectAngiogenesis
dc.subjectNephrectomy
dc.subjectPrognosis
dc.subjectRenal cell cancer
dc.subjectSurvival
dc.titleThe Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS